Apple CEO Steve Jobs received a liver transplant about two months ago but is expected to return to work later this month, reports CNBC's Jim Goldman. David Garrity, of GVA Research, and Mike Abramsky, of RBC Capital, discuss the impact this news may have on the stock.
AOL
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT